We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Faster Measurement of Vibrational Fingerprint of Molecules to Advance Biomedical Diagnostics

By LabMedica International staff writers
Posted on 25 Oct 2024

Identifying different types of molecules and cells is a vital process in both basic and applied science. More...

Raman spectroscopy serves as a widely utilized measurement technique for this purpose. When a laser beam is directed at molecules, the light interacts with the vibrations and rotations of molecular bonds, causing a shift in the frequency of the scattered light. The resulting scattering spectra act as a unique “vibrational fingerprint” for each molecule. Despite its widespread use, there have been numerous efforts to enhance Raman spectroscopy, particularly because one of its main limitations is the measurement rate, which often prevents it from keeping pace with rapid changes in certain chemical and physical reactions. Now, scientists have successfully increased the measurement rate of Raman spectroscopy, paving the way for advancements in various applications such as ultrafast measurements of irreversible phenomena, high-speed hyperspectral Raman imaging, and high-throughput Raman flow cytometry.

Scientists at the Institute for Photon Science and Technology at the University of Tokyo (Tokyo, Japan) set to improve the measurement rate of Raman spectroscopy by building a system from scratch and managed to achieve a 100-fold increase. Since measurement rate has been a critical limitation, this enhancement could facilitate progress in numerous fields that depend on identifying molecules and cells, including biomedical diagnostics and material analysis. Drawing on their expertise in optics and photonics, the scientists integrated three key components: coherent Raman spectroscopy, which generates stronger signals than traditional spontaneous Raman spectroscopy; a specially designed ultrashort pulse laser; and time-stretch technology utilizing optical fibers. The results, published in the journal Ultrafast Science, show that the researchers achieved a measurement rate of 50 MSpectra/s (megaspectra per second), which is a 100-fold increase compared to the previous fastest measurement of 50 kSpectra/s (kilospectra per second). This advancement holds significant potential across a range of applications.

“We aim to apply our spectrometer to microscopy, enabling the capture of 2D or 3D images with Raman scattering spectra,” said Takuro Ideguchi of the Institute for Photon Science and Technology at the University of Tokyo, who was the principal investigator of the study. “Additionally, we envision its use in flow cytometry by combining this technology with microfluidics. These systems will enable high-throughput, label-free chemical imaging and spectroscopy of biomolecules in cells or tissues.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Biomarker Algorithm Clarifies Uncertain Alzheimer’s Amyloid Status

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image

GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

GeneDx (Gaithersburg, MD, USA) is presenting 27 scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting, taking place October 20–24 in Montreal, Canada.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.